CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 235 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,735 | -97.7% | 2,009 | -98.1% | 0.00% | -100.0% |
| Q2 2023 | $2,346,285 | +263.5% | 105,451 | +253.9% | 0.01% | +200.0% |
| Q1 2023 | $645,490 | -76.8% | 29,801 | -78.2% | 0.00% | -80.0% |
| Q4 2022 | $2,777,677 | +40.9% | 136,764 | +77.9% | 0.02% | +25.0% |
| Q3 2022 | $1,971,000 | +160.7% | 76,883 | +141.7% | 0.01% | +100.0% |
| Q2 2022 | $756,000 | -17.3% | 31,804 | -21.6% | 0.01% | -25.0% |
| Q1 2022 | $914,000 | +9.3% | 40,566 | -3.9% | 0.01% | +33.3% |
| Q4 2021 | $836,000 | +43.2% | 42,225 | +42.3% | 0.01% | -14.3% |
| Q3 2021 | $584,000 | +54.1% | 29,665 | +86.2% | 0.01% | +16.7% |
| Q1 2021 | $379,000 | +7.1% | 15,935 | -24.4% | 0.01% | +20.0% |
| Q2 2020 | $354,000 | +128.4% | 21,070 | +62.1% | 0.01% | -16.7% |
| Q1 2020 | $155,000 | – | 13,002 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,188,417 | $85,349,000 | 7.80% |
| TANAKA CAPITAL MANAGEMENT INC | 144,602 | $2,379,000 | 5.69% |
| INGALLS & SNYDER LLC | 6,817,540 | $112,149,000 | 5.47% |
| NEXTHERA CAPITAL LP | 1,045,196 | $17,193,000 | 2.83% |
| Timpani Capital Management LLC | 245,279 | $4,035,000 | 1.41% |
| S&T BANK/PA | 426,257 | $7,012,000 | 1.25% |
| SHAKER INVESTMENTS LLC/OH | 107,670 | $1,771,000 | 1.10% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 434,624 | $7,150,000 | 0.94% |
| AMI ASSET MANAGEMENT CORP | 709,300 | $11,668,000 | 0.83% |
| Birchview Capital, LP | 75,500 | $1,242,000 | 0.82% |